Longchain polyunsaturated fatty acid supplementation in preterm infants

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 12, 2016, Pages

  Moon, Kwi ^a   Rao, Shripada C ^b   Schulzke, Sven M ^c   Patole, Sanjay K ^d   Simmer, Karen ^b  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b KING EDWARD MEMORIAL HOSPITAL   (Australia)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; LONG CHAIN FATTY ACID; POLYUNSATURATED FATTY ACID; UNSATURATED FATTY ACID;

ARTIFICIAL MILK; CINAHL; COCHRANE LIBRARY; GESTATIONAL AGE; HUMAN; MEDICAL LITERATURE; MEDLINE; NERVE CELL DIFFERENTIATION; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; VISION; VISUAL ACUITY; VITAMIN SUPPLEMENTATION; CHEMISTRY; DIETARY SUPPLEMENT; GROWTH, DEVELOPMENT AND AGING; INFANT NUTRITION; INTELLIGENCE; META ANALYSIS; NEWBORN; PHYSIOLOGY;

ARACHIDONIC ACID; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, UNSATURATED; HUMANS; INFANT FORMULA; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; INFANT, PREMATURE; INTELLIGENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VISION, OCULAR; VISUAL ACUITY;

EID: 85006819048     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD000375.pub5     Document Type: Review

References (70)

1. Carlson SE. Lipid requirements of VLBW infants for optimal growth and development. Lipids, Learning and the Brain: Fats in infant formula. Report of the 103rd Ross Conference on Pediatric Research. Columbus, Ohio: Ross Labs, 1993. [2850392]
2. Carlson SE, Cooke RJ, Rhodes PG, Peeples JM, Werkman SH, Tolley EA. Longterm feeding of formulas high in LA and marine oil to VLBW infants: phospholipid fatty acids. Pediatric Research 1991;30(5):404-12. [2850388]
3. Carlson SE, Cooke RJ, Werkman SH, Tolley EA. First year growth of infants fed standard formula compared with marine oil supplemented formula. Lipids 1992;27(11):901-7. [2850389]
4. Carlson SE, Werkman SH, Peeples JM, Cooke RJ, Tolley EA. Arachidonic acid correlates with first year growth in preterm infants. Proceedings of the National Academy of Sciences 1993;90(3):1073-7. [2850390]
5. Carlson SE, Werkman SH, Rhodes PG, Tolley EA. Visual acuity development in healthy preterm infants: effect of marine oil supplementation. American Journal of Clinical Nutrition 1993;58(1):35-42. [2850391]
6. Werkman SH, Carlson SE. A randomised trial of visual attention of preterm infants fed DHA until 9 months. Lipids 1996;31(1):91-7. [2850393]
7. Carlson SE, Werkman SH. A randomised trial of visual attention of preterm infants fed DHA until 2 months. Lipids 1996;31(1):85-90. [2850396]
8. Carlson SE, Werkman SH, Tolley EA. Effect of long chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. American Journal of Clinical Nutrition 1996;63(5):687-97. [2850395]
9. Carnielli VP, Simonato M, Verlato G, Luijendijk I, De Curtis M, Sauer PJJ, et al. Synthesis of long-chain polyunsaturated fatty acids in preterm newborns fed formula with long-chain polyunsaturated fatty acids. American Journal of Clinical Nutrition 2007;86(5):1323-30. [2850398]
10. Clandinin MT, Van Aerde JE, Parrott A, Field CJ, Euler AR, Lien EL. Assessment of the efficacious dose of arachidonic and docosahexaenoic acids in preterm infant formulas: fatty acid composition of erythrocyte membrane lipids. Pediatric Research 1997;42(6):819-25. [2850400]
11. Clandinin MT, Van Aerde JE, Merkel KL, Harris CL, Springer MA, Hansen JW, et al. Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. Journal of Pediatrics 2005;146(4):461-8. [2850402]
12. Diersen-Schade DA, Hansen JW, Harris CL, Merkel KL, Wisont KD, Boettcher JA. Docosahexaenoic acid plus arachidonic acid enhance preterm infant growth. In: Riemersma RA, Armstrong R, Kelly RW, Wilson R editor(s). Essential Fatty Acids & Eicosanoids: Invited Papers from the Fourth International Congress. Champaign, IL: AOCS Press, 1998:123-7. [2850416]
13. Fadella G, Giovani M, Alessandroni R, et al. Visual evoked potentials and dietary LCPUFA in preterm infants. Archives of Disease in Childhood 1996;75:F108-12. [2850404]
14. Fang PC, Kuo HK, Huang CB, Ko TY, Chen CC, Chung MY. The effect of supplementation of docosahexaenoic acid and arachidonic acid on visual acuity and neurodevelopment in larger preterm infants. Chang Gung Medical Journal 2005;28(10):708-15. [2850406]
15. Fewtrell MS, Morley R, Abbott RA, Singhal A, Isaacs EB, Stephenson T, MacFayden U, Lucas A. Double-blind, randomised trial of long-chain polyunsaturated fatty acids in formula fed to preterm infants. Pediatrics 2002;110(1 Pt 1):73-82. [2850408]
16. Fewtrell MS, Abbott RA, Kennedy K, Singhal A, Morley R, Caine E, et al. Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. Journal of Pediatrics 2004;144(4):471-9. [2850410]
17. Isaacs EB, Ross S, Kennedy K, Weaver LT, Lucas A, Fewtrell MS. 10-year cognition in preterms after random assignment to fatty acid supplementation in infancy. Pediatrics 2011;128(4):e890-8. [2850411]
18. Kennedy K, Ross S, Isaacs EB, Weaver LT, Singhal A, Lucas A, et al. The 10-year follow-up of a randomised trial of long-chain polyunsaturated fatty acid supplementation in preterm infants: effects on growth and blood pressure. Archives of Disease in Childhood 2010;95(8):588-95. [2850412]
19. Groh-Wargo S, Jacobs J, Auestad N, O'Connor DL, Moore JJ, Lerner E. Body composition in preterm infants who are fed long-chain polyunsaturated fatty acids: A prospective, randomized, controlled trial. Pediatric Research 2005;57(5 Pt 1):712-8. [2850414]
20. Innis SM, Adamkin DH, Hall RT, Kalhan SC, Lair C, Lim M, et al. Docosahexanoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula. Journal of Pediatrics 2002;140(5):547-54. [2850418]
21. Lapillonne A, Picaud JC, Chirouze V, Goudable J, Reygrobellet B, Claris O, et al. The use of low-EPA fish oil for long-chain polyunsaturated fatty acid supplementation of preterm infants. Pediatric Research 2000;48(6):835-41. [2850420]
22. O'Connor DL, Hall R, Adamkin D, Austead N, Castillo M, Connor WE, et al. Growth and development in preterm infants fed longchain polyunsaturated fatty acids: A prospective randomised trial. Pediatrics 2001;108(2):359-71. [2850422]
23. Birch DG, Birch EE, Hoffman DR, Uauy RD. Retinal development of very low birthweight infants fed diets differing in n-3 fatty acids. Investigative Ophthalmology & Visual Science 1992;33(8):2365-76. [2850424]
24. Hoffman DR, Uauy R. Essentiality of dietary n-3 fatty acids for premature infants; plasma and red blood cell fatty acid composition. Lipids 1992;27(11):886-95. [2850425]
25. Uauy R, Hoffman DR, Birch EE, Birch DG, Jameson DM, Tyson J. Safety and efficacy of n-3 fatty acids in the nutrition of very low birthweight infants: soy oil and marine oil supplementation of formula. Journal of Pediatrics 1994;124(4):612-20. [2850426]
26. Uauy RD, Birch DG, Birch EE, Tyson JE, Hoffman DR. Effect of dietary omega 3 fatty acids on retinal function of very low birthweight neonates. Pediatric Research 1990;28:485-92. [2850427]
27. Vanderhoof J, Gross S, Hegyi T. A multicenter long-term safety and efficacy trial of preterm formula supplemented with long-chain polyunsaturated fatty acids. Journal of Pediatric Gastroenterology and Nutrition 2000;31(2):121-7. [2850430]
28. Vanderhoof J, Gross S, Hegyi T, Clandinin T, Porcelli P, DeCristofaro J, et al. Evaluation of a long-chain polyunsaturated fatty acid supplemented formula on growth, tolerance, and plasma lipids in preterm infants up to 48 weeks postconceptional age. Journal of Pediatric Gastroenterology and Nutrition 1999;29(3):318-26. [2850429]
29. van Wezel-Meijler G, van der Knaap MS, Huisman J, Jonkman EJ, Valk J, Lafeber HN. Dietary supplementation of long-chain polyunsaturated fatty acids in preterm infants: effects on cerebral maturation. Acta Paediatrica 2002;91(9):942-50. [2850432]
30. Almaas AN, Tamnes CK, Nakstad B, Henriksen C, Walhovd KB, Fjell AM, et al. Long-chain polyunsaturated fatty acids and cognition in VLBW infants at 8 years: an RCT. Pediatrics 2015;135(6):972-80. [2850434]
31. Alshweki A, Muñuzuri AP, Baña AM, de Castro MJ, Andrade F, Aldamiz- Echevarria L, et al. Effects of different arachidonic acid supplementation on psychomotor developement in very perterm infants; a randomised controlled trial. Nutrition Journal 2015;14:101. [2850436]
32. Baack M, Puumala SE, Messier SE, Pritchett DK, Harris WS. Daily enteral DHA supplementation alleviates deficiency in premature infants. Lipids 2016;51(4):423-33. [2850438]
33. Collins CT, Makride M, Gibson RA, Ryan P, McPhee AJ. Growth outcomes from the DINO (DHA for the improvement of neurodevelopmental outcome in preterm infants) trial. Journal of Paediatric and Child Health. 2010; Vol. 46:76. [2850440]
34. Collins CT, Makrides M, Gibson RA, McPhee AJ, Davids PG, Doyle LW, et al. Pre- and post-term growth in pre-term infants supplemented with higher-dose DHA: a randomised controlled trial. British Journal of Nutrition 2011;105(11):1635-43. [2850442]
35. Collins CT, Gibson RA, Anderson PJ, McPhee AJ, Sullivan TR, Gould JF, et al. Neurodevelopmental outcomes at 7 years corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow up of a randomised controlled trial. BMJ Open 2015;5(3):e007314. [2850444]
36. Donzelli GP, Cafaggi L, Rapisardi G, Moroni M, Pratesi S. Longchain polyunsaturated fatty acids and early neural and visual development in preterm infants. Pediatric Research 1996;40:527. [2850446]
37. Koletzko B, Sauerwald U, Keicher U, Saule H, Wawatschek S, Boehles H, et al. Fatty acid profiles, antioxidant status, and growth of preterm infants fed diets without or with long-chain polyunsaturated fatty acids - a randomized clinical trial. European Journal of Nutrition 2003;42(5):243-53. [2850448]
38. Lim M, Antonson D, Clandinin M, vanAerde J, Green D, Stevens K, et al. Formulas with DHA and ARA for LBW infants are safe. Pediatric Research 2002;51:319A. [2850450]
39. Makrides M, Gibson RA, McPhee AJ, Collins CT, David PG, Doyle LW, et al. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid. Journal of the American Medical Association 2009;301(2):175-82. [2850452]
40. Rodriguez A, Raederstorff D, Sarda P, Lauret C, Mendy F, Descomps B. Preterm infant formula supplementation with alpha linoleic acid and docosahexaenoic acid. European Journal of Clinical Nutrition 2003;57(6):727-34. [2850454]
41. Shah D. Is there any benefit of supplementing infant milk formulae with long chain polyunsaturated fatty acids. Indian Pediatrics 2009;46(9):783-4. [2850456]
42. Smithers LG, Gibson RA, McPhee A, Makrides M. Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: Results from the DINO trial. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2008;79(3-5):141-6. [2850458]
43. Smithers LG, Gibson RA, McPhee A, Makrides M. Higher dose of docosaheaenoic acid in the neonatal period improves visual acuity of preterm infants: results of a randomized controlled trial. American Journal of Clinical Nutrition 2008;88(4):1049-56. [2850462]
44. Smithers LG, Collins CT, Simmonds LA, Gibson RA, McPhee AJ, Makrides M. Higher-dose docosahexaenoic acid(DHA) does not influence language or behaviour: A follow up of the DINO (DHA for the improvement of neurodevelopemental outcome in preterm infants) trial. Journal of Paediatrics and Child Health. 2010; Vol. 46 (suppl.1):39. [2850460]
45. van de Lagemaat M, Rotteveel J, Muskiet FAJ, Schaafsma A, Lafeber HL. Post term dietary- induced changes in DHA and AA status relate to gains in weight, length, and head circumference in preterm infants. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2011;85(6):311-6. [2850464]
46. Anderson JW, Johnstone BM, Remley DT. Breast-feeding and cognitive development: a meta-analysis. The American Journal of Clinical Nutrition 1999;70(4):525-35.
47. Beyerlein A, Hadder-Algra M, Kennedy K, Fewtrell M, Singhal A, Rosenfeld E, et al. Infant formula supplementation with long-chain polyunsaturated fatty acids has no effect on bayley developmental scores at 18 months of age- IPD meta-analysis of 4 large clinical trials. Journal of Pediatric Gastroenterology and Nutrition 2010;50(1):79-84.
48. Bjerve KS, Bredde OL, Bonaa K, Johnson H, Vatten L, Vik T. Clinical and epidemiological studies with alpha linolenic acid and longchain n-3 fatty acids. In: Sinclair AJ, Gibson RA editor(s). Third International Conference on Essential Fatty Acids and Eicosanoids. Illinois: AOCS, March 1992.
49. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. Intrauterine fatty acid secretion rates in human brain: implications for fatty acid requirements. Early Human Development 1980;4(2):121-9.
50. Clark KJ, Makrides M, Neumann MA, Gibson RA. Determination of the optimal ratio of linoleic acid to alpha linolenic acid in infant formulas. Journal of Pediatrics 1992;120(4 Pt 2):S151-8.
51. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
52. Fagan JF 3rd. Memory in the infant. Journal of Experimental Child Psychology 1970;9(2):217-26.
53. Fagan JF, Singer LT. Infant recognition memory as a measure of intelligence. In: Lipsitt LP editor(s). Advances in Infant Research. Vol. 2, Ablex, Norwood, 1983:31-72.
54. GRADE Working Group, McMaster University. GRADEpro GDT. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
55. Henriksen C, Haugholt K, Lindgren M, Aurvåg AK, Rønnestad A, Grønn M, et al. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics 2008;121(6):1137-45.
56. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
57. Jiao J, Li Q, Chu J, Zeng W, Yang M, Zhu S. Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: a systematic review and meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition 2014;100(6):1422-36.
58. Kramer MS, Aboud F, Mironova E, Vanilovich I, Platt RW, Matush L, et al. Breastfeeding and child cognitive development: new evidence from a large randomized trial. Archives of General Psychiatry 2008;65(5):578-84.
59. Lucas A, Morley R, Cole TJ, Lister G, Leeson-Payne C. Breastmilk and subsequent intelligence quotient in children born preterm. Lancet 1992;339(8788):261-4.
60. Makrides M, Simmer K, Goggin M, Gibson RA. Erythrocyte docosahexaenoic acid correlates with the visual response of the healthy, term infant. Pediatric Research 1993;33(4 Pt 1):425-7.
61. Makrides M, Kleinman RE. The long and short of it: Long-chain fatty acids and long-term outcomes for premature infants. Pediatrics 2015;135(6):1128-9.
62. Meldrum SJ, Smith MA, Prescott SL, Hird K, Simmer K. Achieving definitive results in long-chain polyunsaturated fatty acid supplementation trials of term infants: factors for consideration. Nutrition Reviews 2011;69(4):205-14.
63. Morrow-Tlucak M, Haude RH, Ernhart CB. Breastfeeding and cognitive development in the first two years of life. Social Science & Medicine 1988;26(6):635-9.
64. Neuringer M, Connor WE, Lin DS, Barstad L, Luck S. Biochemical and functional effects of prenatal and postnatal n-3 fatty acids on retina and brain in rhesus monkeys. Proceedings of the National Academy of Sciences USA 1986;83(11):4021-5.
65. Qawasmi A, Landeros-Weisenberger A, Bloch MH. Meta-analysis of LCPUFA supplementaion of infant formulae and visual acuity. Pediatrics 2013;131(1):e262-72.
66. Schünemann H, Brozek J, Guyatt G, Oxman A, editors. GRADE Working Group. GRADE handbook for grading quality of evidence and strength of recommendations. Available from www.guidelinedevelopment.org/handbook Updated October 2013.
67. Schulzke S, Patole S, Simmer K. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI:10.1002/14651858.CD000375.pub4]
68. Simmer K. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI:10.1002/14651858.CD000375]
69. Simmer K, Patole S. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI:10.1002/14651858.CD000375.pub2]
70. Simmer K, Schulzke S2, Patole S. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD000375.pub3]